Five Out Of Six Studies On MDMA Show Positive Results, Yet FDA Approval Still Faces Hurdles
The potential of MDMA-assisted therapy (MDMA-AT) for treating post-traumatic stress disorder (PTSD) has garnered significant attention, including many scientific studies that indicate promising results. However, while the majority of the results suggest safety and efficacy, researchers emphasize the need for more robust investigations before MDMA-AT can be broadly adopted.
Promising Results And Significant Findings
As reported by Marijuana Moment, a review published in the Journal of Psychedelic Studies revealed that five out of six studies on MDMA for PTSD showed positive results, with participants in full-dose MDMA treatment experiencing greater improvements on the primary outcome measure. “Participants in full-dose MDMA treatment arms have shown statistically greater improvements on the primary outcome measure (CAPS) in 5/6 studies (83.3%),” the review states. These results are considered encouraging, yet the authors call for further research to solidify these findings.
Long-Lasting Benefits And Minor Risks
The analysis shows that Phase III trials have demonstrated significant and long-lasting effects, with benefits lasting up to a year post-intervention. Additionally, the risks associated with MDMA administration were found to be relatively minor. …